• To enhance your awareness of the skills required for educating patients about anticancer therapy
• To find advice and resources for delivering effective pre-treatment patient education sessions
• To contribute towards revalidation as part of your 35 hours of CPD (UK readers)
• To contribute towards your professional development and local registration renewal requirements (non-UK readers)
Systemic anticancer therapy (SACT) incorporates all types of therapies used to treat cancer, including cytotoxic therapy (also called chemotherapy), immunotherapy, hormonal therapies and targeted therapies. Nurse-led pre-SACT patient education sessions aim to inform patients about their treatment, including its potential side effects and what they should do if they experience symptoms, to enhance patient safety and to reinforce informed consent. This article discusses the importance of pre-SACT patient education sessions in the context of cytotoxic therapy and details six areas for nurses to consider when planning on delivering such sessions.
Cancer Nursing Practice. doi: 10.7748/cnp.2024.e1875
Peer reviewThis article has been subject to external double-blind peer review and checked for plagiarism using automated software
Correspondence Conflict of interestNone declared
Gayle S (2024) Delivering a pre-systemic anticancer therapy patient education session. Cancer Nursing Practice. doi: 10.7748/cnp.2024.e1875
Published online: 30 September 2024
or
Are you a student? Our student subscription has content especially for you.
Find out more
